Pulse Biosciences PLSE
Valuation
Multiples measured against the stock's own five-year history
Near the bottom of its 5-year range · 4th percentile, 5-year average -13.0x
Near the top of its 5-year range · 81st percentile, 5-year average 9.6x
#5141 of 5330 stocks by PB (1 = cheapest)
Near the top of its 5-year range · 83rd percentile, 5-year average -40,504.2x
#5115 of 5155 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 20.21 | – | 9.63 | 81% (pricier than usual) | #5141 of 5330 (1 = cheapest) |
| PE | -41.69 | -36.41 | -12.95 | 4% (cheaper than usual) | – |
| PS | 2,483.14 | 1,066.04 | -40,504.22 | 83% (pricier than usual) | #5115 of 5155 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on PLSE.
Sign in to join the discussion.